Chinese herbal medicine Guilu erxian jiao attenuates bone marrow suppression following chemotherapy in patients with advanced lung cancer


Autor: YanChen et al.


Journal: Translational Metabolic Syndrome Research, englisch


In recent decades, a classic recipe in traditional Chinese medicine, Guilu erxian jiao (GEJ), has been used in the prevention and treatment of myelosuppression following cancer chemotherapy. However, the safety and efficacy of GEJ has not been studied. In the present study, we investigated the safety and efficacy of GEJ in the management of myelosuppression in a cohort of advanced lung adenocarcinoma patients who received 4 cycles of chemotherapy. Treatment with GEJ was compared to the conventional treatment with pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF).

The GEJ treatment group (38 patients) was orally administered GEJ whilst the control group (25 patients) were treated with PEG-rhG-CSF during the 4 cycles of chemotherapy. We found that GEJ was as safe as the recommended treatment, PEG-rhG-CSF. GEJ patients recovered from suppressed bone marrow in a much steadier approach, compared with the highly fluctuating changes observed in PEG-rhG-CSF treatment. Our data suggests that GEJ may be a better alternative to manage cancer chemotherapy-induced myelosuppression.


Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea
Yincong Xu e al.; 2020

Review on the potential action mechanisms of Chinese medicines in treating Coronavirus
Yu-Feng Huang et al; 2020

Aktuelle Artenschutzprobleme im Kontext der Traditionellen Chinesischen Medizin
Altherr Sandra; 2020




 
 

Vorheriger Artikel

Übersicht

Nächster Artikel
 

Link zum Journal